|
2645 REVIEW DENIED Statements made before legislative bodies by a drug manufacturer seeking to influence legislation arose from the exercise of the constitutional right to petition, and were protected by the SLAPP statute; statements made in marketing a drug used by more than 1.8 million people related to a public issue, and were protected by the SLAPP statute.CitationDuPONT MERCK v SUPERIOR COURT (Coumadin) 78 CA4 562 [See: CCP 425.16; Briggs v Eden Council 19 C4 1106, T/AT 2/99; Wilcox v Superior Court 27 CA4 809, T/AT 9/94; Dixon v Superior Court 30 CA4 733, T/AT 1/95; Zauderer v Office of Disciplinary Counsel 471 US 626; Johnson's v NLRB 461 US 731]
|
|
